Abstract 22
Hospital acquired infection is a major cause of morbidity and mortality and regimes to 23 prevent infection are crucial in infection control. These include decolonisation of at-risk 24 patients of carriage of MRSA which is commonly achieved by protocols that include the use 25 of chlorhexidine, or octenidine as biocidal agents. There is however no standardised single 26 decolonisation regime agreed upon in the UK or other countries and protocols include a 27 variety of active agents. Antibiotic resistant bacteria cause major problems in hospital 28 medicine and concern has been raised regarding the development of biocide resistance 29 which would cause decolonisation regimes to become unreliable. In this study, we 30 assembled a panel of isolates of S. aureus including isolates collected before the 31 development of chlorhexidine and octenidine through to a contemporaneous panel of 32 isolates from a major hospital trust in the UK during a period when the decolonisation regime 33 was altered. We observed significant increases in the MIC and MBC of chlorhexidine in 34 isolates collected from periods of high usage of chlorhexidine. No isolates had a significantly 35 altered MIC or MBC of octenidine apart from those collected after octenidine was introduced 36
Introduction 57
Antiseptics, and especially chlorhexidine, have been used widely as one of the key 58 measures implemented in the control of infections caused by methicillin resistant 59
Staphylococcus aureus (MRSA) in hospitals. The most widely used approach has been to 60 use antiseptics as part of a decolonisation protocol for patients who are known to be 61 colonised with MRSA in conjunction with nasal mupirocin. However, in some units, 62 especially intensive care units, antiseptics have been used universally for washing of all 63 patients (Climo et al., 2013) . 64
Chlorhexidine, which was first synthesised in 1954 (Davies et al., 1954) , is the most widely 65 used antiseptic. It is a cationic biguanide agent that acts by disrupting the bacterial cell 66 five and six of their study, but then decreasing in the following two years (Warren et al., 99 2016) . There have also been case reports of the selection of isolates with an increase in 100 chlorhexidine MIC in patients receiving chlorhexidine as part of a decolonisation regime 101 (Johnson et al., 2015) . 102
Despite the reporting of isolates with reduced antiseptic susceptibility, the clinical impact of 103 this is unclear with antiseptics being used at much higher concentrations than the typical 104 MIC or MBC of these isolates. However, there are reports of clinical failures of 105
Materials and Methods 116
A panel of 157 S. aureus and methicillin resistant S. aureus strains isolated between 1928 117 and 2014 were included in the study (Table 1) The minimum inhibitory concentrations (MIC) of each agent were determined using broth 138 microdilution (following recommendations from EUCAST) ranging in concentration from 139 0.0029µg/ml to 3µg/ml for octenidine dihydrochloride and 0.0625µg/ml to 64µg/ml for 140 chlorhexidine digluconate. Minimum bactericidal concentrations (MBC) were subsequently 141 determined by inoculation of 10 µl of suspensions following determinations of MICs onto LB 142 agar and observing growth after overnight incubation. The presence of qacA/B was 143 determined in all samples using mutliplex PCR (Vali et al., 2008) . Results 160
Usage of chlorhexidine and octenidine 161
The use of chlorhexidine and octenidine was analysed in our hospital showing a decrease in 162 usage of chlorhexidine and an increase in octenidine use across the study period. The 163 usage of chlorhexidine decreased from 7,061 packs being dispensed in 2009 to 5091 in 164 2014. In contrast, the usage of octenidine dihydrochloride has increased markedly, with 165 none being prescribed in or before 2013, increasing to 18,844 bottles in 2014. 166
Biocide susceptibility of isolates 167
The MIC and MBC of chlorhexidine was significantly different between the four groups. 168
Chlorhexidine MICs ranged from 0.5 µg/ml to 32 µg/ml, with a significant increase in the 169 mean MICs over time from group 1 to 3, with then a slight reduction in group 4 compared to 170 group 3 ( Figure 1 ). This increase in mean MIC was a result of a shift of susceptibility of most 171 isolates in the population requiring higher MICs rather than being a result of a small sub-172 population of highly resistant isolates. The MBCs of chlorhexidine showed a similar pattern, 173 the percentage of isolates with an MBC >32 µg/ml increased from group 1 to 3, with 0, 5.5 174 and 36.5% of isolates having an MBC >32 µg/ml in groups 1, 2 and 3 respectively (Figure 3) . 175
The differences in MIC and MBC distributions between the groups were not likely to be 176 random according to statistical tests (chi-squared and Mann-Whitney tests both returned p 177 values <0.05 comparing groups 3 and 4 and 1 and 2). 178
The MIC and MBC of octenidine dihydrochloride were both lower than chlorhexidine and 179 ranged from 0.09375 µg/ml to 1.5 µg/ml. The MBC of octenidine was stable against isolates 180 in groups 1-3 with all isolates being inhibited by 0.0375-0.75 µg/ml. Isolates with a markedly 181 decreased susceptibility were however isolated in group 4 after introduction of this agent 182 ( Figures 1 and 2) . The difference between MIC and MBC values for the final group (4) and 183 other groups was statistically significant (P <0.05). 184
Interestingly, there was no correlation between susceptibility to the two agents, i.e. a raised 185 chlorhexidine MIC was not likely to be reflected by a raised octendine dihydrochloride MIC in 186 the same isolate (tested using Pearson's correlation test). 187
The changes in susceptibilty to both agents reflected usage data although it was not 188 possible to statistically analyse these changes.
VNTR analysis of the isolates revealed CC22 to be the most predominant clonal complex, 191 which is the endemic strain within the UK. The other two clonal complexes represented were 192 CC36 and CC8 (Figure 3) . 193
The phylogenetic analysis failed to identify a specific clone or lineage which showed reduced 
Genomic analysis of ST22 isolates 211
Sixteen strains with related VNTR profiles from groups 3 and four and a range of 212 chlorhexidine MBCs were whole genome sequenced and mechanisms which may contribute 213 to decreased susceptiblity to chlorhexidine were identified. Figure 4 shows the phylogeny of 214 these strains based on a whole genome alignment (produced by ROARY). Comparisons of core genes attempted to identify common changes in those isolates with highest MBCs. 217 There were no common accessory genes identified or carriage of a known resistance 218 mechanism that correlates with biocide resistance. To further try and identify a tolerance 219 mechanism two pairs of strains with four fold differences in susceptibilty (by MBC) but which 220 were very closely related according to the phlogeny were compared for changes (strains 3 221 vs 7 and strain 2 vs the reference ST22; HO_5096_041, Figure 5 ). Analysis of these strain respectively), the two more resistant isolates both had changes in either of two homologous 224 efflux pump systems; NorA and NorB. Both have been shown to export multiple agents 225 including biocides (DeMarco et al., 2007) . Strain 2 carried a SNP within norB that results in a 226 change of the NorB protein of Met314Ile. This substitution is adjacent to the predicted 227 translocation pore and may alter the capacity of this strain to export chlorhexidine compared 228 to the reference. Strain 7 had a wild-type norB allele but carried a SNP within norA resulting 229 in a change in NorA of Ala362Val. Substitution at this site has previously been shown to 230 improve efflux capacity of the protein for some substrates (Kaatz et al., 1993) . None of the 231 other sequenced strains had changes within either system or in their known regulators. 232 233
Discussion 234
This study has highlighted that the increasing use of chlorhexidine and octenidine 235 dihydrochloride is associated with emergence of reduced susceptibility to each agent in S. 236 aureus. As described in previous studies (Wang et al., 2008; Liu et al., 2015) the number of 237 S. aureus and especially MRSA isolates demonstrating reduced susceptibility to 238 chlorhexidine increased over time, which in the current study was most marked when the 239 MRSA epidemic was at its peak within the UK. 240
There have only been a limited number of studies that have investigated reduced 241 susceptibility to chlorhexidine longitudinally and all have been over shorter time periods. 242
Historical isolates included in this study from a period of no antiseptic usage had very low 243 MIC and MBC and increases were then observed in groups two and three. Interestingly 244 unlike other longitudinal studies where there have been similar observations we did observe 245 a reduction in the MICs in the fourth time period. This can be correlated with a reduction in 246 the number of MRSA infections within the UK and reduction in chlorhexidine usage in our 247
hospital. 248
We also demonstrate a reduction in susceptibility to octenidine following universal suggests that it is unlikely that these isolates will affect clinical efficacy, but they have 260 emerged in a real world situation suggesting there is a significant benefit which has been 261 selected in practice. Interestingly, octenidine dihydrochloride was only in use for one year 262 before there was a marked change in the susceptibility of isolates. 263
For both biocides, isolates with decreased susceptibility were not clonal which suggests 264 there has been no emergence of a dominant clone which may have an advantage in the 265 face of either biocide. The fact that isolates with decreased susceptibility are seen in various strain backgrounds suggests that the capacity to develop this phenotype is common to many 267 strains and, presumably results from a change in the S. aureus core genome. This differs to 268 previous reports where there has been spread of a dominant clone with reduced 269 susceptibility (Otter et al., 2013) . 270
As highlighted by the review by Harbarth and colleagues the increased usage of antiseptics 271 has not been matched by an increase in surveillance, both microbiological and clinical 272 (Harbarth et al., 2014). One of the reasons for the lack of surveillance is the lack of both 273 standardised testing methodology and definitions for resistance. The majority of studies have 274 utilised MICs, but the methodologies vary and the technique is less applicable for antiseptics 275
where the lethal rather than the inhibitory concentration needs to be measured and MBC 276 testing is more meaningful. As there is no standardised testing methodology there has been 277 no national or international agreement regarding an appropriate cut off for defining systems as a mechanism to increase efficiency of export of substrates. Mutation within the 304 structural pump protein of a multidrug efflux system was also recently shown to increase 305 efficiency of export of some substrates at the expense of others (Blair et al., 2015) . The 306 substitutions within NorB (adjacent to the translocation pore) and NorA (known to alter pump 307 efficiency for fluoroquinolone export) identified here may reflect adaptation to increase 308 efficiency of chlorhexidine export. 309
There is an obvious need for more research in this area to provide better surveillance data 310 from larger populations and geographical regimes, and to understand the mechanisms of 311 action and resistance to antiseptics better. The significance and clinical impact of the 312 emergence of isolates with decreased susceptibility to decolonisation regimes remains 313 uncertain. However, the introduction of chlorhexidine and octenidine dihydrochloride has 314 changed the susceptibility of the S. aureus population compared to pre-biocide times and 315 they are therefore having an ecological impact. The consequences of this remain unclear. 
